Breast Cancer Trials
S1207
S1207 – Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor-positive and HER2/Neu negative breast cancer.
-
What type of cancer? What stage?
- Early stage breast cancer – Stage 1, 2, and 3
-
Who is eligible?
- Women who are ER/PR+ but Her2-
-
How will I be treated?
- Women may also receive Everolimus – an mTOR inhibitor
A5481082
A5481082 – Palbociclib in hormone receptor positive advanced breast cancer: a prospective multi center non-interventional study
-
What type of cancer? What stage?
- Triple negative breast cancer
-
Who is eligible?
- Women with inoperable or metastatic disease
-
How will I be treated?
- Women may also receive palcociclib (Ibrance), which is used to treat ER+ breast cancer.
For physicians: more information about this specific trial at clinicaltrials.gov.
-
Metairie, LA 70006
504.988.6300 More information -
Metairie, LA 70006
504.456.5000 More information -
Metairie, LA 70006
504.503.6289 More information
-
Each year in the U.S., nearly 2 million people are diagnosed with some type of cancer. If a friend or ...
Continue Reading -
At your last checkup, your primary care provider recommended you schedule a breast cancer screening this ...
Continue Reading -
Let’s start with some good news: colorectal cancer diagnoses and mortality rates are on the decline. ...
Continue Reading -
When you own a house, you take care of it with regular maintenance. When you own a car, you take it to ...
Continue Reading -
If you’ve been diagnosed with cancer, you want the care of a team of experts. You’ll find that through ...
Continue Reading